Global Health Data Exchange - Discover the World's Health Data

SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals. Preprint

Nav

General Info
Geography 
Qatar (QAT)
Time period covered 
01/2020 - 12/2020
Citation
Authors 
Coyle PV, Chemaitelly H, Kacem MABH, Molawi NHAA, Kahlout RAE, Gilliani I, Younes N, Kanaani ZA, Khal AA, Kuwari EA, Butt AA, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Rahim HFA, Nasrallah GK, Yassine HM, Kuwari MGA, Romaihi HEA, Al-Thani MH, Bertollini R, Abu-Raddad LJ
Journal 
medRxiv
Publication year 
2021
Suggested citation 
Coyle PV, Chemaitelly H, Kacem MABH, Molawi NHAA, Kahlout RAE, Gilliani I, Younes N, Kanaani ZA, Khal AA, Kuwari EA, Butt AA, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Rahim HFA, Nasrallah GK, Yassine HM, Kuwari MGA, Romaihi HEA, Al-Thani MH, Bertollini R, Abu-Raddad LJ. SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals. Preprint. medRxiv. 2021.
DOI 
10.1101/2021.01.05.21249247